Sorafenib Stada 200 mg filmom obložene tablete
| Name | Sorafenib Stada 200 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-666859771 |
| Active Substance | sorafenibtosilat |
| Composition | jedna filmom obložena tableta sadrži 200 mg sorafeniba (u obliku sorafenibtosilata) |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Remedica Ltd., Limassol, Cipar STADA Arzneimittel AG, Bad Vilbel, Njemačka STADA Arzneimittel GmbH, Beč, Austrija PharOS MT Ltd, Birzebbugia, Malta Laboratori Fundacio Dau, Barcelona, Španjolska |
| Marketing Authorisation Holder | Stada d.o.o., Hercegovačka 14, Zagreb, Hrvatska |
| Marketing Authorisation Date | 27.01.2025 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/24-02/108 |
| Registration Number | 381-12-01/70-25-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01EX02 |
| Marketing status | Temporarily unavailable |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
